US Stock MarketDetailed Quotes

EVLO Evelo Biosciences

Watchlist
  • 0.001
  • 0.0000.00%
15min DelayClose Feb 5 12:53 ET
9.49KMarket Cap0.00P/E (TTM)

Evelo Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
53.92%-10.41M
25.25%-19.83M
29.92%-20.28M
-4.66%-101.24M
16.72%-23.19M
16.86%-22.59M
-71.89%-26.53M
-10.09%-28.93M
-32.39%-96.73M
-46.92%-27.85M
Net income from continuing operations
59.55%-12.36M
30.95%-21.1M
15.14%-25.34M
6.26%-114.53M
17.84%-23.54M
9.39%-30.56M
3.28%-30.56M
-5.91%-29.86M
-30.44%-122.18M
1.37%-28.65M
Operating gains losses
143.87%2.47M
--26K
-371.12%-629K
-57.94%1.35M
1,016.67%110K
11,144.44%1.01M
--0
--232K
53,750.00%3.22M
-1,100.00%-12K
Depreciation and amortization
-65.30%169K
-20.45%424K
-13.93%445K
-7.04%2.06M
-2.79%523K
-17.18%487K
-3.79%533K
-3.54%517K
9.38%2.22M
0.94%538K
Other non cash items
55.99%1.95M
54.37%866K
60.91%885K
108.66%4.39M
292.05%2.02M
147.92%1.25M
9.57%561K
-3.34%550K
-10.55%2.1M
-7.69%516K
Change In working capital
-298.18%-3.49M
-280.06%-4.02M
131.32%1.46M
-567.41%-9.67M
-24.34%-5.73M
72.84%1.76M
-113.05%-1.06M
-89.36%-4.65M
-73.37%2.07M
-169.45%-4.61M
-Change in prepaid assets
14.24%1.97M
31.61%-1.03M
201.29%1.02M
-86.17%-1.16M
35.78%-359K
137.05%1.72M
-80.72%-1.51M
-2,297.83%-1.01M
-141.38%-622K
-145.23%-559K
-Change in payables and accrued expense
-402.69%-3.83M
-349.19%-2.47M
139.06%1.21M
-109.23%-5.44M
-40.18%-4.58M
61.84%1.26M
-48.78%990K
-52.13%-3.11M
-131.41%-2.6M
-155.36%-3.27M
-Change in other current liabilities
-33.72%-1.63M
3.15%-522K
-48.86%-783K
-38.85%-3.07M
-0.90%-783K
-150.92%-1.22M
-9.55%-539K
-15.35%-526K
-9.84%-2.21M
-51.56%-776K
-Change in other working capital
----
----
----
----
----
----
----
----
--7.5M
--0
Cash from discontinued investing activities
Operating cash flow
53.92%-10.41M
25.25%-19.83M
29.92%-20.28M
-4.66%-101.24M
16.72%-23.19M
16.86%-22.59M
-71.89%-26.53M
-10.09%-28.93M
-32.39%-96.73M
-46.92%-27.85M
Investing cash flow
Cash flow from continuing investing activities
5,800.00%513K
0
92.16%-12K
58.00%-622K
-148.00%-228K
98.89%-9K
72.15%-232K
51.27%-153K
-12.62%-1.48M
216.14%475K
Net PPE purchase and sale
5,800.00%513K
--0
92.16%-12K
58.00%-622K
-148.00%-228K
98.89%-9K
72.15%-232K
51.27%-153K
-12.62%-1.48M
216.14%475K
Cash from discontinued investing activities
Investing cash flow
5,800.00%513K
--0
92.16%-12K
58.00%-622K
-148.00%-228K
98.89%-9K
72.15%-232K
51.27%-153K
-12.62%-1.48M
216.14%475K
Financing cash flow
Cash flow from continuing financing activities
2,790.23%19.22M
0
-270.09%-199K
-16.29%81.66M
1,480.16%1.74M
100.91%665K
427.31%79.13M
-99.86%117K
49.00%97.54M
-101.88%-126K
Net issuance payments of debt
----
----
----
-121.13%-3.12M
---3.12M
----
----
----
47.78%14.78M
--0
Net common stock issuance
4,019.49%24.31M
----
----
3.42%84.54M
2,415.24%4.86M
900.00%590K
----
----
48.65%81.75M
-103.20%-210K
Proceeds from stock option exercised by employees
-98.67%1K
--0
-72.09%36K
-76.85%234K
--0
-72.43%75K
-90.91%30K
-60.31%129K
114.65%1.01M
-36.36%84K
Net other financing activities
---37K
--0
-1,858.33%-235K
----
----
----
----
---12K
----
----
Cash from discontinued financing activities
Financing cash flow
2,790.23%19.22M
--0
-270.09%-199K
-16.29%81.66M
1,480.16%1.74M
100.91%665K
427.31%79.13M
-99.86%117K
49.00%97.54M
-101.88%-126K
Net cash flow
Beginning cash position
-90.57%8.78M
-29.81%28.63M
-29.61%49.1M
-0.95%69.75M
-27.81%70.21M
-25.41%93.16M
-67.67%40.79M
-0.95%69.75M
-11.23%70.42M
17.06%97.25M
Current changes in cash
142.52%9.33M
-137.86%-19.83M
29.28%-20.49M
-2,933.33%-20.2M
21.16%-21.68M
20.67%-21.93M
4,263.43%52.38M
-151.98%-28.97M
92.53%-666K
-117.20%-27.5M
Effect of exchange rate changes
95.21%-49K
---18K
--17K
---454K
--568K
---1.02M
--0
--0
--0
--0
End cash Position
-74.28%18.06M
-90.57%8.78M
-29.81%28.63M
-29.61%49.1M
-29.61%49.1M
-27.81%70.21M
-25.41%93.16M
-67.67%40.79M
-0.95%69.75M
-0.95%69.75M
Free cash flow
53.73%-10.46M
25.90%-19.83M
30.25%-20.29M
-3.68%-101.86M
14.54%-23.42M
19.24%-22.6M
-64.47%-26.76M
-9.37%-29.09M
-32.08%-98.24M
-41.53%-27.4M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 53.92%-10.41M25.25%-19.83M29.92%-20.28M-4.66%-101.24M16.72%-23.19M16.86%-22.59M-71.89%-26.53M-10.09%-28.93M-32.39%-96.73M-46.92%-27.85M
Net income from continuing operations 59.55%-12.36M30.95%-21.1M15.14%-25.34M6.26%-114.53M17.84%-23.54M9.39%-30.56M3.28%-30.56M-5.91%-29.86M-30.44%-122.18M1.37%-28.65M
Operating gains losses 143.87%2.47M--26K-371.12%-629K-57.94%1.35M1,016.67%110K11,144.44%1.01M--0--232K53,750.00%3.22M-1,100.00%-12K
Depreciation and amortization -65.30%169K-20.45%424K-13.93%445K-7.04%2.06M-2.79%523K-17.18%487K-3.79%533K-3.54%517K9.38%2.22M0.94%538K
Other non cash items 55.99%1.95M54.37%866K60.91%885K108.66%4.39M292.05%2.02M147.92%1.25M9.57%561K-3.34%550K-10.55%2.1M-7.69%516K
Change In working capital -298.18%-3.49M-280.06%-4.02M131.32%1.46M-567.41%-9.67M-24.34%-5.73M72.84%1.76M-113.05%-1.06M-89.36%-4.65M-73.37%2.07M-169.45%-4.61M
-Change in prepaid assets 14.24%1.97M31.61%-1.03M201.29%1.02M-86.17%-1.16M35.78%-359K137.05%1.72M-80.72%-1.51M-2,297.83%-1.01M-141.38%-622K-145.23%-559K
-Change in payables and accrued expense -402.69%-3.83M-349.19%-2.47M139.06%1.21M-109.23%-5.44M-40.18%-4.58M61.84%1.26M-48.78%990K-52.13%-3.11M-131.41%-2.6M-155.36%-3.27M
-Change in other current liabilities -33.72%-1.63M3.15%-522K-48.86%-783K-38.85%-3.07M-0.90%-783K-150.92%-1.22M-9.55%-539K-15.35%-526K-9.84%-2.21M-51.56%-776K
-Change in other working capital ----------------------------------7.5M--0
Cash from discontinued investing activities
Operating cash flow 53.92%-10.41M25.25%-19.83M29.92%-20.28M-4.66%-101.24M16.72%-23.19M16.86%-22.59M-71.89%-26.53M-10.09%-28.93M-32.39%-96.73M-46.92%-27.85M
Investing cash flow
Cash flow from continuing investing activities 5,800.00%513K092.16%-12K58.00%-622K-148.00%-228K98.89%-9K72.15%-232K51.27%-153K-12.62%-1.48M216.14%475K
Net PPE purchase and sale 5,800.00%513K--092.16%-12K58.00%-622K-148.00%-228K98.89%-9K72.15%-232K51.27%-153K-12.62%-1.48M216.14%475K
Cash from discontinued investing activities
Investing cash flow 5,800.00%513K--092.16%-12K58.00%-622K-148.00%-228K98.89%-9K72.15%-232K51.27%-153K-12.62%-1.48M216.14%475K
Financing cash flow
Cash flow from continuing financing activities 2,790.23%19.22M0-270.09%-199K-16.29%81.66M1,480.16%1.74M100.91%665K427.31%79.13M-99.86%117K49.00%97.54M-101.88%-126K
Net issuance payments of debt -------------121.13%-3.12M---3.12M------------47.78%14.78M--0
Net common stock issuance 4,019.49%24.31M--------3.42%84.54M2,415.24%4.86M900.00%590K--------48.65%81.75M-103.20%-210K
Proceeds from stock option exercised by employees -98.67%1K--0-72.09%36K-76.85%234K--0-72.43%75K-90.91%30K-60.31%129K114.65%1.01M-36.36%84K
Net other financing activities ---37K--0-1,858.33%-235K-------------------12K--------
Cash from discontinued financing activities
Financing cash flow 2,790.23%19.22M--0-270.09%-199K-16.29%81.66M1,480.16%1.74M100.91%665K427.31%79.13M-99.86%117K49.00%97.54M-101.88%-126K
Net cash flow
Beginning cash position -90.57%8.78M-29.81%28.63M-29.61%49.1M-0.95%69.75M-27.81%70.21M-25.41%93.16M-67.67%40.79M-0.95%69.75M-11.23%70.42M17.06%97.25M
Current changes in cash 142.52%9.33M-137.86%-19.83M29.28%-20.49M-2,933.33%-20.2M21.16%-21.68M20.67%-21.93M4,263.43%52.38M-151.98%-28.97M92.53%-666K-117.20%-27.5M
Effect of exchange rate changes 95.21%-49K---18K--17K---454K--568K---1.02M--0--0--0--0
End cash Position -74.28%18.06M-90.57%8.78M-29.81%28.63M-29.61%49.1M-29.61%49.1M-27.81%70.21M-25.41%93.16M-67.67%40.79M-0.95%69.75M-0.95%69.75M
Free cash flow 53.73%-10.46M25.90%-19.83M30.25%-20.29M-3.68%-101.86M14.54%-23.42M19.24%-22.6M-64.47%-26.76M-9.37%-29.09M-32.08%-98.24M-41.53%-27.4M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Argo Blockchain
ARBK
+5.33%
Strategy
MSTR
+3.94%
BTCS Inc
BTCS
+3.20%
Canaan
CAN
+2.29%
Bit Origin
BTOG
+1.90%

Unlock the Full List